IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2025 Holdings

Filed 2025-11-14 | 8 holdings | $180.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Innoviva Inc(INVA)COM45781M101$51.4M2,816,02228.5%
Neurocrine Biosciences Inc(NBIX)COM64125C109$42.6M303,15123.6%
Cytokinetics Inc(CYTK)COM NEW23282W605$32.3M588,35717.9%
Ironwood Pharmaceuticals Inc(IRWD)COM CL A46333X108$20.9M15,919,43511.6%
Amarin Corp PLC(EH3)SPONSORED ADR023111404$20.4M1,242,52711.3%
Lantheus Hldgs Inc(LNTH)COM516544103$9.3M181,4505.2%
Regeneron Pharmaceuticals(REGN)COM75886F107$2.4M4,1901.3%
VOR Biopharma Inc(VOR)COM NEW929033207$1.2M25,3990.7%